Clinical Trial Update: A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of MAG200 as an intra-articular injection for knee osteoarthritis, comparing MAG200 to placebo in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• MAG200

Snippet

Sponsor: Magellan Stem Cells | Conditions: Knee Osteoarthristis | Phase 3 | Status: NOT_YET_RECRUITING